TY - JOUR AU - Gomez-Outes, A. AU - Suarez-Gea, M. L. AU - Calvo-Rojas, G. AU - Lecumberri, R. AU - Rocha, E. AU - Pozo-Hernandez, C. PY - 2012 DA - 2012// TI - Discovery of anticoagulant drugs: a historical perspective JO - Curr Drug Discov Technol. VL - 9 UR - https://doi.org/10.2174/1570163811209020083 DO - 10.2174/1570163811209020083 ID - Gomez-Outes2012 ER - TY - JOUR AU - Hylek, E. M. AU - Evans-Molina, C. AU - Shea, C. AU - Henault, L. E. AU - Regan, S. PY - 2007 DA - 2007// TI - Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation JO - Circulation. VL - 115 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.653048 DO - 10.1161/CIRCULATIONAHA.106.653048 ID - Hylek2007 ER - TY - JOUR AU - Fang, M. C. AU - Go, A. S. AU - Chang, Y. AU - Borowsky, L. H. AU - Pomernacki, N. K. AU - Udaltsova, N. PY - 2010 DA - 2010// TI - Warfarin discontinuation after starting warfarin for atrial fibrillation JO - Circ Cardiovasc Qual Outcomes. VL - 3 UR - https://doi.org/10.1161/CIRCOUTCOMES.110.937680 DO - 10.1161/CIRCOUTCOMES.110.937680 ID - Fang2010 ER - TY - JOUR AU - Eriksson, B. I. AU - Quinlan, D. J. AU - Weitz, J. I. PY - 2009 DA - 2009// TI - Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development JO - Clin Pharmacokinet. VL - 48 UR - https://doi.org/10.2165/0003088-200948010-00001 DO - 10.2165/0003088-200948010-00001 ID - Eriksson2009 ER - TY - JOUR AU - Connolly, S. J. AU - Ezekowitz, M. D. AU - Yusuf, S. AU - Eikelboom, J. AU - Oldgren, J. AU - Parekh, A. PY - 2009 DA - 2009// TI - Dabigatran versus warfarin in patients with atrial fibrillation JO - N Engl J Med. VL - 361 UR - https://doi.org/10.1056/NEJMoa0905561 DO - 10.1056/NEJMoa0905561 ID - Connolly2009 ER - TY - JOUR AU - Eikelboom, J. W. AU - Wallentin, L. AU - Connolly, S. J. AU - Ezekowitz, M. AU - Healey, J. S. AU - Oldgren, J. PY - 2011 DA - 2011// TI - Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial JO - Circulation. VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.004747 DO - 10.1161/CIRCULATIONAHA.110.004747 ID - Eikelboom2011 ER - TY - JOUR AU - Connolly, S. J. AU - Wallentin, L. AU - Ezekowitz, M. D. AU - Eikelboom, J. AU - Oldgren, J. AU - Reilly, P. A. PY - 2013 DA - 2013// TI - The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) study JO - Circulation. VL - 128 UR - https://doi.org/10.1161/CIRCULATIONAHA.112.001139 DO - 10.1161/CIRCULATIONAHA.112.001139 ID - Connolly2013 ER - TY - JOUR AU - Tamayo, S. AU - Frank Peacock, W. AU - Patel, M. AU - Sicignano, N. AU - Hopf, K. P. AU - Fields, L. E. PY - 2015 DA - 2015// TI - Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban JO - Clin Cardiol. VL - 38 UR - https://doi.org/10.1002/clc.22373 DO - 10.1002/clc.22373 ID - Tamayo2015 ER - TY - JOUR AU - Southworth, M. R. AU - Reichman, M. E. AU - Unger, E. F. PY - 2013 DA - 2013// TI - Dabigatran and postmarketing reports of bleeding JO - N Engl J Med. VL - 368 UR - https://doi.org/10.1056/NEJMp1302834 DO - 10.1056/NEJMp1302834 ID - Southworth2013 ER - TY - JOUR AU - Hernandez, I. AU - Baik, S. H. AU - Pinera, A. AU - Zhang, Y. PY - 2015 DA - 2015// TI - Risk of bleeding with dabigatran in atrial fibrillation JO - JAMA Intern Med. VL - 175 UR - https://doi.org/10.1001/jamainternmed.2014.5398 DO - 10.1001/jamainternmed.2014.5398 ID - Hernandez2015 ER - TY - JOUR AU - Stangier, J. AU - Clemens, A. PY - 2009 DA - 2009// TI - Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor JO - Clin Appl Thromb Hemost. VL - 15 UR - https://doi.org/10.1177/1076029609343004 DO - 10.1177/1076029609343004 ID - Stangier2009 ER - TY - JOUR AU - Vilchez, J. A. AU - Gallego, P. AU - Lip, G. Y. PY - 2014 DA - 2014// TI - Safety of new oral anticoagulant drugs: a perspective JO - Ther Adv Drug Saf. VL - 5 UR - https://doi.org/10.1177/2042098613507945 DO - 10.1177/2042098613507945 ID - Vilchez2014 ER - TY - JOUR AU - Poulsen, B. K. AU - Grove, E. L. AU - Husted, S. E. PY - 2012 DA - 2012// TI - New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function JO - Drugs. VL - 72 UR - https://doi.org/10.2165/11635730-000000000-00000 DO - 10.2165/11635730-000000000-00000 ID - Poulsen2012 ER - TY - STD TI - Pradaxa prescribing information. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf. Accessed 19 Oct 2015. UR - http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf ID - ref14 ER - TY - STD TI - European Medicines Agency. Pradaxa 110 mg hard capsules summary of product characteristics. https://www.medicines.org.uk/emc/medicine/20760/SPC/Pradaxa+110+mg+hard+capsules/. Accessed 19 Oct 2015. UR - https://www.medicines.org.uk/emc/medicine/20760/SPC/Pradaxa+110+mg+hard+capsules/ ID - ref15 ER - TY - JOUR AU - Huttner, H. B. AU - Schellinger, P. D. AU - Hartmann, M. AU - Kohrmann, M. AU - Juettler, E. AU - Wikner, J. PY - 2006 DA - 2006// TI - Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates JO - Stroke. VL - 37 UR - https://doi.org/10.1161/01.STR.0000221786.81354.d6 DO - 10.1161/01.STR.0000221786.81354.d6 ID - Huttner2006 ER - TY - JOUR AU - Grottke, O. AU - Honickel, M. AU - Ryn, J. AU - Cate, H. AU - Rossaint, R. AU - Spronk, H. M. H. PY - 2015 DA - 2015// TI - Idarucizumab, a specific dabigatran reversal agent, reduces blood loss in a porcine model of trauma with dabigatran anticoagulation JO - J Am Coll Cardiol. VL - 66 UR - https://doi.org/10.1016/j.jacc.2015.07.051 DO - 10.1016/j.jacc.2015.07.051 ID - Grottke2015 ER - TY - JOUR AU - Honickel, M. AU - Treutler, S. AU - Ryn, J. AU - Tillmann, S. AU - Rossaint, R. AU - Grottke, O. PY - 2015 DA - 2015// TI - Reversal of dabigatran anticoagulation ex-vivo: porcine study comparing prothrombin complex concentrates and idarucizumab JO - Thromb Haemost. VL - 113 UR - https://doi.org/10.1160/TH14-08-0712 DO - 10.1160/TH14-08-0712 ID - Honickel2015 ER - TY - JOUR AU - Pollack, C. V. AU - Reilly, P. A. AU - Eikelboom, J. AU - Glund, S. AU - Verhamme, P. AU - Bernstein, R. A. PY - 2015 DA - 2015// TI - Idarucizumab for dabigatran reversal JO - N Engl J Med. VL - 373 UR - https://doi.org/10.1056/NEJMoa1502000 DO - 10.1056/NEJMoa1502000 ID - Pollack2015 ER - TY - JOUR AU - Levy, J. H. AU - Faraoni, D. AU - Spring, J. L. AU - Douketis, J. D. AU - Samama, C. M. PY - 2013 DA - 2013// TI - Managing new oral anticoagulants in the perioperative and intensive care unit setting JO - Anesthesiology. VL - 118 UR - https://doi.org/10.1097/ALN.0b013e318289bcba DO - 10.1097/ALN.0b013e318289bcba ID - Levy2013 ER - TY - JOUR AU - Siegal, D. M. AU - Cuker, A. PY - 2013 DA - 2013// TI - Reversal of novel oral anticoagulants in patients with major bleeding JO - J Thromb Thrombolysis. VL - 35 UR - https://doi.org/10.1007/s11239-013-0885-0 DO - 10.1007/s11239-013-0885-0 ID - Siegal2013 ER - TY - JOUR AU - Steiner, T. AU - Bohm, M. AU - Dichgans, M. AU - Diener, H. C. AU - Ell, C. AU - Endres, M. PY - 2013 DA - 2013// TI - Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban JO - Clin Res Cardiol. VL - 102 UR - https://doi.org/10.1007/s00392-013-0560-7 DO - 10.1007/s00392-013-0560-7 ID - Steiner2013 ER - TY - JOUR AU - Dumkow, L. E. AU - Voss, J. R. AU - Peters, M. AU - Jennings, D. L. PY - 2012 DA - 2012// TI - Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma JO - Am J Health Syst Pharm. VL - 69 UR - https://doi.org/10.2146/ajhp120055 DO - 10.2146/ajhp120055 ID - Dumkow2012 ER - TY - JOUR AU - Carter, A. AU - Sarda, P. AU - George, M. AU - Corbett, S. PY - 2014 DA - 2014// TI - Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage JO - Ann R Coll Surg Engl. VL - 96 UR - https://doi.org/10.1308/003588414X13824511649779 DO - 10.1308/003588414X13824511649779 ID - Carter2014 ER - TY - JOUR AU - Hankey, G. J. AU - Eikelboom, J. W. PY - 2011 DA - 2011// TI - Dabigatran etexilate: a new oral thrombin inhibitor JO - Circulation. VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.004424 DO - 10.1161/CIRCULATIONAHA.110.004424 ID - Hankey2011 ER - TY - JOUR AU - Spinler, S. PY - 2013 DA - 2013// TI - The pharmacology and therapeutic use of dabigatran etexilate JO - J Clin Pharmacol. VL - 53 ID - Spinler2013 ER - TY - JOUR AU - Adams, R. L. AU - Bird, R. J. PY - 2009 DA - 2009// TI - Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants JO - Nephrology (Carlton) VL - 14 UR - https://doi.org/10.1111/j.1440-1797.2009.01128.x DO - 10.1111/j.1440-1797.2009.01128.x ID - Adams2009 ER - TY - JOUR AU - Kozek-Langenecker, S. A. AU - Afshari, A. AU - Albaladejo, P. AU - Santullano, C. A. AU - Robertis, E. AU - Filipescu, D. C. PY - 2013 DA - 2013// TI - Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology JO - Eur J Anaesthesiol. VL - 30 UR - https://doi.org/10.1097/EJA.0b013e32835f4d5b DO - 10.1097/EJA.0b013e32835f4d5b ID - Kozek-Langenecker2013 ER - TY - JOUR AU - Faraoni, D. AU - Levy, J. H. AU - Albaladejo, P. AU - Samama, C. M. PY - 2015 DA - 2015// TI - Groupe d’Intérêt en Hémostase Périopératoire JO - Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care. VL - 19 ID - Faraoni2015 ER - TY - JOUR AU - Heidbuchel, H. AU - Verhamme, P. AU - Alings, M. AU - Antz, M. AU - Diener, H. C. AU - Hacke, W. PY - 2015 DA - 2015// TI - Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation JO - Europace. VL - 17 UR - https://doi.org/10.1093/europace/euv309 DO - 10.1093/europace/euv309 ID - Heidbuchel2015 ER - TY - JOUR AU - Ryn, J. AU - Stangier, J. AU - Haertter, S. AU - Liesenfeld, K. H. AU - Wienen, W. AU - Feuring, M. PY - 2010 DA - 2010// TI - Dabigatran etexilate—a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity JO - Thromb Haemost. VL - 103 UR - https://doi.org/10.1160/TH09-11-0758 DO - 10.1160/TH09-11-0758 ID - Ryn2010 ER - TY - JOUR AU - Weitz, J. I. AU - Quinlan, D. J. AU - Eikelboom, J. W. PY - 2012 DA - 2012// TI - Periprocedural management and approach to bleeding in patients taking dabigatran JO - Circulation. VL - 126 UR - https://doi.org/10.1161/CIRCULATIONAHA.112.123224 DO - 10.1161/CIRCULATIONAHA.112.123224 ID - Weitz2012 ER - TY - JOUR AU - Dager, W. E. PY - 2013 DA - 2013// TI - Developing a management plan for oral anticoagulant reversal JO - Am J Health Syst Pharm. VL - 70 UR - https://doi.org/10.2146/ajhp130042 DO - 10.2146/ajhp130042 ID - Dager2013 ER - TY - JOUR AU - Bundgaard-Nielsen, M. AU - Secher, N. H. AU - Kehlet, H. PY - 2009 DA - 2009// TI - ‘Liberal’ vs. ‘restrictive’ perioperative fluid therapy—a critical assessment of the evidence JO - Acta Anaesthesiol Scand VL - 53 UR - https://doi.org/10.1111/j.1399-6576.2009.02029.x DO - 10.1111/j.1399-6576.2009.02029.x ID - Bundgaard-Nielsen2009 ER - TY - JOUR AU - Corcoran, T. AU - Rhodes, J. E. AU - Clarke, S. AU - Myles, P. S. AU - Ho, K. M. PY - 2012 DA - 2012// TI - Perioperative fluid management strategies in major surgery: a stratified meta-analysis JO - Anesth Analg. VL - 114 UR - https://doi.org/10.1213/ANE.0b013e318240d6eb DO - 10.1213/ANE.0b013e318240d6eb ID - Corcoran2012 ER - TY - JOUR AU - Boland, M. R. AU - Noorani, A. AU - Varty, K. AU - Coffey, J. C. AU - Agha, R. AU - Walsh, S. R. PY - 2013 DA - 2013// TI - Perioperative fluid restriction in major abdominal surgery: systematic review and meta-analysis of randomized, clinical trials JO - World J Surg. VL - 37 UR - https://doi.org/10.1007/s00268-013-1987-8 DO - 10.1007/s00268-013-1987-8 ID - Boland2013 ER - TY - JOUR AU - Frith, D. AU - Davenport, R. AU - Brohi, K. PY - 2012 DA - 2012// TI - Acute traumatic coagulopathy JO - Curr Opin Anaesthesiol. VL - 25 UR - https://doi.org/10.1097/ACO.0b013e3283509675 DO - 10.1097/ACO.0b013e3283509675 ID - Frith2012 ER - TY - JOUR AU - Grottke, O. AU - Fries, D. AU - Nascimento, B. PY - 2015 DA - 2015// TI - Perioperatively acquired disorders of coagulation JO - Curr Opin Anaesthesiol. VL - 28 UR - https://doi.org/10.1097/ACO.0000000000000176 DO - 10.1097/ACO.0000000000000176 ID - Grottke2015 ER - TY - JOUR AU - Fawole, A. AU - Daw, H. A. AU - Crowther, M. A. PY - 2013 DA - 2013// TI - Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban JO - Cleve Clin J Med. VL - 80 UR - https://doi.org/10.3949/ccjm.80a.13025 DO - 10.3949/ccjm.80a.13025 ID - Fawole2013 ER - TY - JOUR AU - Ryn, J. AU - Grottke, O. AU - Spronk, H. PY - 2014 DA - 2014// TI - Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays JO - Clin Lab Med. VL - 34 UR - https://doi.org/10.1016/j.cll.2014.06.008 DO - 10.1016/j.cll.2014.06.008 ID - Ryn2014 ER - TY - JOUR AU - Hawes, E. M. AU - Deal, A. M. AU - Funk-Adcock, D. AU - Gosselin, R. AU - Jeanneret, C. AU - Cook, A. M. PY - 2013 DA - 2013// TI - Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels JO - J Thromb Haemost. VL - 11 UR - https://doi.org/10.1111/jth.12308 DO - 10.1111/jth.12308 ID - Hawes2013 ER - TY - JOUR AU - Stangier, J. AU - Stahle, H. AU - Rathgen, K. AU - Fuhr, R. PY - 2008 DA - 2008// TI - Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects JO - Clin Pharmacokinet. VL - 47 UR - https://doi.org/10.2165/00003088-200847010-00005 DO - 10.2165/00003088-200847010-00005 ID - Stangier2008 ER - TY - JOUR AU - Dager, W. E. AU - Gosselin, R. C. AU - Kitchen, S. AU - Dwyre, D. PY - 2012 DA - 2012// TI - Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study JO - Ann Pharmacother. VL - 46 UR - https://doi.org/10.1345/aph.1R179 DO - 10.1345/aph.1R179 ID - Dager2012 ER - TY - JOUR AU - Alikhan, R. AU - Rayment, R. AU - Keeling, D. AU - Baglin, T. AU - Benson, G. AU - Green, L. PY - 2014 DA - 2014// TI - The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran JO - Emerg Med J. VL - 31 UR - https://doi.org/10.1136/emermed-2012-201976 DO - 10.1136/emermed-2012-201976 ID - Alikhan2014 ER - TY - JOUR AU - Curvers, J. AU - Kerkhof, D. AU - Stroobants, A. K. AU - Dool, E. J. AU - Scharnhorst, V. PY - 2012 DA - 2012// TI - Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful? JO - Am J Clin Pathol. VL - 138 UR - https://doi.org/10.1309/AJCPQOD9WFPEYY0H DO - 10.1309/AJCPQOD9WFPEYY0H ID - Curvers2012 ER - TY - JOUR AU - Javedani, P. P. AU - Horowitz, B. Z. AU - Clark, W. M. AU - Lutsep, H. L. PY - 2013 DA - 2013// TI - Dabigatran etexilate: management in acute ischemic stroke JO - Am J Crit Care. VL - 22 UR - https://doi.org/10.4037/ajcc2013125 DO - 10.4037/ajcc2013125 ID - Javedani2013 ER - TY - JOUR AU - Dinkelaar, J. AU - Patiwael, S. AU - Harenberg, J. AU - Leyte, A. AU - Brinkman, H. J. PY - 2014 DA - 2014// TI - Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate JO - Clin Chem Lab Med. VL - 52 ID - Dinkelaar2014 ER - TY - JOUR AU - Herrmann, R. AU - Thom, J. AU - Wood, A. AU - Phillips, M. AU - Muhammad, S. AU - Baker, R. PY - 2014 DA - 2014// TI - Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban JO - Thromb Haemost. VL - 111 UR - https://doi.org/10.1160/TH13-07-0607 DO - 10.1160/TH13-07-0607 ID - Herrmann2014 ER - TY - JOUR AU - Grottke, O. AU - Ryn, J. AU - Spronk, H. M. AU - Rossaint, R. PY - 2014 DA - 2014// TI - Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model JO - Crit Care. VL - 18 UR - https://doi.org/10.1186/cc13717 DO - 10.1186/cc13717 ID - Grottke2014 ER - TY - JOUR AU - Cotton, B. A. AU - McCarthy, J. J. AU - Holcomb, J. B. PY - 2011 DA - 2011// TI - Acutely injured patients on dabigatran JO - N Engl J Med. VL - 365 UR - https://doi.org/10.1056/NEJMc1111095 DO - 10.1056/NEJMc1111095 ID - Cotton2011 ER - TY - JOUR AU - Grottke, O. AU - Levy, J. H. PY - 2015 DA - 2015// TI - Prothrombin complex concentrates in trauma and perioperative bleeding JO - Anesthesiology. VL - 122 UR - https://doi.org/10.1097/ALN.0000000000000608 DO - 10.1097/ALN.0000000000000608 ID - Grottke2015 ER - TY - JOUR AU - Holland, L. AU - Warkentin, T. E. AU - Refaai, M. AU - Crowther, M. A. AU - Johnston, M. A. AU - Sarode, R. PY - 2009 DA - 2009// TI - Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose JO - Transfusion. VL - 49 UR - https://doi.org/10.1111/j.1537-2995.2008.02080.x DO - 10.1111/j.1537-2995.2008.02080.x ID - Holland2009 ER - TY - JOUR AU - Quinlan, D. J. AU - Eikelboom, J. W. AU - Weitz, J. I. PY - 2013 DA - 2013// TI - Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding JO - Circulation. VL - 128 ID - Quinlan2013 ER - TY - JOUR AU - Zhou, W. AU - Schwarting, S. AU - Illanes, S. AU - Liesz, A. AU - Middelhoff, M. AU - Zorn, M. PY - 2011 DA - 2011// TI - Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran JO - Stroke. VL - 42 UR - https://doi.org/10.1161/STROKEAHA.111.624650 DO - 10.1161/STROKEAHA.111.624650 ID - Zhou2011 ER - TY - JOUR AU - Pragst, I. AU - Zeitler, S. H. AU - Doerr, B. AU - Kaspereit, F. J. AU - Herzog, E. AU - Dickneite, G. PY - 2012 DA - 2012// TI - Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model JO - J Thromb Haemost. VL - 10 UR - https://doi.org/10.1111/j.1538-7836.2012.04859.x DO - 10.1111/j.1538-7836.2012.04859.x ID - Pragst2012 ER - TY - JOUR AU - Herzog, E. AU - Kaspereit, F. J. AU - Krege, W. AU - Doerr, B. AU - Ryn, J. AU - Dickneite, G. PY - 2014 DA - 2014// TI - Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model JO - Thromb Res. VL - 134 UR - https://doi.org/10.1016/j.thromres.2014.07.003 DO - 10.1016/j.thromres.2014.07.003 ID - Herzog2014 ER - TY - JOUR AU - Honickel, M. AU - Maron, B. AU - Ryn, J. AU - Braunschweig, T. AU - Cate, H. AU - Spronk, H. M. H. PY - 2016 DA - 2016// TI - Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model JO - Thromb Haemost VL - 115 UR - https://doi.org/10.1160/TH15-03-0266 DO - 10.1160/TH15-03-0266 ID - Honickel2016 ER - TY - JOUR AU - Honickel, M. AU - Braunschweig, T. AU - Ryn, J. AU - Cate, H. AU - Spronk, H. AU - Rossaint, R. PY - 2015 DA - 2015// TI - Prothrombin complex concentrate is effective in treating the anticoagulant effects of dabigatran in a porcine polytrauma model JO - Anesthesiology VL - 123 UR - https://doi.org/10.1097/ALN.0000000000000863 DO - 10.1097/ALN.0000000000000863 ID - Honickel2015 ER - TY - JOUR AU - Eerenberg, E. S. AU - Kamphuisen, P. W. AU - Sijpkens, M. K. AU - Meijers, J. C. AU - Buller, H. R. AU - Levi, M. PY - 2011 DA - 2011// TI - Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects JO - Circulation. VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.029017 DO - 10.1161/CIRCULATIONAHA.111.029017 ID - Eerenberg2011 ER - TY - JOUR AU - Marlu, R. AU - Hodaj, E. AU - Paris, A. AU - Albaladejo, P. AU - Cracowski, J. L. AU - Pernod, G. PY - 2012 DA - 2012// TI - Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers JO - Thromb Haemost. VL - 108 UR - https://doi.org/10.1160/TH12-03-0179 DO - 10.1160/TH12-03-0179 ID - Marlu2012 ER - TY - JOUR AU - Schulman, S. AU - Ritchie, B. AU - Goy, J. K. AU - Nahirniak, S. AU - Almutawa, M. AU - Ghanny, S. PY - 2014 DA - 2014// TI - Activated prothrombin complex concentrate for dabigatran-associated bleeding JO - Br J Haematol. VL - 164 UR - https://doi.org/10.1111/bjh.12620 DO - 10.1111/bjh.12620 ID - Schulman2014 ER - TY - JOUR AU - Masotti, L. AU - Lorenzini, G. AU - Seravalle, C. AU - Panigada, G. AU - Landini, G. AU - Cappelli, R. PY - 2015 DA - 2015// TI - Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report JO - J Thromb Thrombolysis. VL - 39 UR - https://doi.org/10.1007/s11239-014-1112-3 DO - 10.1007/s11239-014-1112-3 ID - Masotti2015 ER - TY - JOUR AU - Lillo-Le Louet, A. AU - Wolf, M. AU - Soufir, L. AU - Galbois, A. AU - Dumenil, A. S. AU - Offenstadt, G. PY - 2012 DA - 2012// TI - Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation JO - Thromb Haemost. VL - 108 UR - https://doi.org/10.1160/TH12-03-0149 DO - 10.1160/TH12-03-0149 ID - Lillo-Le Louet2012 ER - TY - JOUR AU - Levy, J. H. AU - Tanaka, K. A. AU - Dietrich, W. PY - 2008 DA - 2008// TI - Perioperative hemostatic management of patients treated with vitamin K antagonists JO - Anesthesiology. VL - 109 UR - https://doi.org/10.1097/ALN.0b013e3181895bd8 DO - 10.1097/ALN.0b013e3181895bd8 ID - Levy2008 ER - TY - JOUR AU - Franchini, M. AU - Lippi, G. PY - 2010 DA - 2010// TI - Prothrombin complex concentrates: an update JO - Blood Transfus. VL - 8 ID - Franchini2010 ER - TY - JOUR AU - Dusel, C. H. AU - Grundmann, C. AU - Eich, S. AU - Seitz, R. AU - Konig, H. PY - 2004 DA - 2004// TI - Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates JO - Blood Coagul Fibrinolysis. VL - 15 UR - https://doi.org/10.1097/01.mbc.0000114437.81125.2b DO - 10.1097/01.mbc.0000114437.81125.2b ID - Dusel2004 ER - TY - JOUR AU - Schochl, H. AU - Voelckel, W. AU - Maegele, M. AU - Kirchmair, L. AU - Schlimp, C. J. PY - 2014 DA - 2014// TI - Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients JO - Crit Care. VL - 18 UR - https://doi.org/10.1186/cc13982 DO - 10.1186/cc13982 ID - Schochl2014 ER - TY - JOUR AU - Grottke, O. AU - Braunschweig, T. AU - Spronk, H. M. AU - Esch, S. AU - Rieg, A. D. AU - Oerle, R. PY - 2011 DA - 2011// TI - Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury JO - Blood. VL - 118 UR - https://doi.org/10.1182/blood-2011-03-343046 DO - 10.1182/blood-2011-03-343046 ID - Grottke2011 ER - TY - JOUR AU - Hess, J. R. AU - Brohi, K. AU - Dutton, R. P. AU - Hauser, C. J. AU - Holcomb, J. B. AU - Kluger, Y. PY - 2008 DA - 2008// TI - The coagulopathy of trauma: a review of mechanisms JO - J Trauma. VL - 65 UR - https://doi.org/10.1097/TA.0b013e3181877a9c DO - 10.1097/TA.0b013e3181877a9c ID - Hess2008 ER - TY - JOUR AU - Harr, J. N. AU - Moore, E. E. AU - Wohlauer, M. V. AU - Droz, N. AU - Fragoso, M. AU - Banerjee, A. PY - 2011 DA - 2011// TI - The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength JO - J Surg Res. VL - 170 ID - Harr2011 ER -